Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “T Lymphocyte Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00000756
What this trial is testing

Evaluation of the Safety and Tolerance of Immunotherapy With Autologous, Ex-Vivo Expanded, HIV-Specific Cytotoxic T-Cells in HIV-Infected Patients With CD4+ Counts Between 100-400/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 15
Not applicableUnknownNCT01668381
What this trial is testing

Enumeration and Function Analysis of Treg Cells in Peripheral Blood of HCC Patients Before and After Ablation Therapy

Who this might be right for
Hepatocellular Carcinoma
First Affiliated Hospital, Sun Yat-Sen University 20
Not applicableStudy completedNCT01089400
What this trial is testing

Immuno-virological Characterization of Severe H1N1v Influenza Infection in Bronchoalveolar Lavage

Who this might be right for
InfluenzaAcute Lung InjuryAcute Respiratory Distress Syndrome
Institut National de la Santé Et de la Recherche Médicale, France 30
Not applicableStudy completedNCT02493413
What this trial is testing

The Stress-release Effects of Exercise in Obese Are Determined by DS14 Score and T-cell Activation Status

Who this might be right for
ObesityType D PersonalityCoronary Heart Disease
Institute for Preventive Medicine, Trzaska 30
Early research (Phase 1)Active Not RecruitingNCT07000149
What this trial is testing

Investigate the Efficacy and Safety of Volrustomig ± Casdatifan vs Nivolumab + Ipilimumab as 1L Treatment for Advanced ccRCC

Who this might be right for
Advanced Clear Cell Renal Cell Carcinoma
AstraZeneca 9
Testing effectiveness (Phase 2)Study completedNCT00025662
What this trial is testing

Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS

Who this might be right for
Graft vs Host DiseaseMyelodysplastic SyndromesLeukemia+7 more
National Heart, Lung, and Blood Institute (NHLBI) 23
Testing effectiveness (Phase 2)Looking for participantsNCT06640582
What this trial is testing

TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas

Who this might be right for
Brain TumorBrain MetastasesBrain Cancer+4 more
Essen Biotech 85
Testing effectiveness (Phase 2)Study completedNCT04305054
What this trial is testing

Substudy 02B: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With First Line (1L) Advanced Melanoma (MK-3475-02B/KEYMAKER-U02)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 335
Early research (Phase 1)UnknownNCT04126590
What this trial is testing

Phase I Study of KN044 in Locally Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumors
Changchun Intellicrown Pharmaceutical Co. LTD 39
Large-scale testing (Phase 3)Study completedNCT00008359
What this trial is testing

Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00076180
What this trial is testing

Hu-Mik-beta1 to Treat T-Cell Large Granular Lymphocytic Leukemia

Who this might be right for
T-Cell Large Granular Lymphocytic LeukemiaLeukemia, T-Cell Large Granular Lymphocytic
National Cancer Institute (NCI) 9
Early research (Phase 1)Active Not RecruitingNCT03354390
What this trial is testing

HERV-E TCR Transduced Autologous T Cells in People With Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Kidney Cancer
National Heart, Lung, and Blood Institute (NHLBI) 17
Testing effectiveness (Phase 2)Looking for participantsNCT04197596
What this trial is testing

Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)

Who this might be right for
Viral InfectionPrimary Immune Deficiency Disorder
New York Medical College 40
Early research (Phase 1)Study completedNCT02168140
What this trial is testing

CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma

Who this might be right for
Adult Lymphocyte Depletion Hodgkin LymphomaAdult Lymphocyte Predominant Hodgkin LymphomaAdult Mixed Cellularity Hodgkin Lymphoma+14 more
Wake Forest University Health Sciences 16
Not applicableUnknownNCT01513408
What this trial is testing

Relevance of T Lymphocytes Tumor Infiltrates CD8 and Foxp3 as Immune Prognostic Biomarker in Breast Cancer Treated by Neo Adjuvant Chemotherapy

Who this might be right for
Breast Cancer
Centre Georges Francois Leclerc 500
Not applicableStudy completedNCT04707820
What this trial is testing

Antiviral T Lymphocyte Immunity During Acute COVID-19 Infection

Who this might be right for
Corona Virus Infection
University Hospital, Rouen 51
Early research (Phase 1)Study completedNCT03905135
What this trial is testing

Interleukin-15 (IL-5) in Combination With Avelumab (Bavencio) in Relapsed/Refractory Mature T-cell Malignancies

Who this might be right for
Peripheral T-cell Lymphoma NOSMycosis FungoidesSezary Syndrome+1 more
National Cancer Institute (NCI) 8
Testing effectiveness (Phase 2)UnknownNCT06006390
What this trial is testing

CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors

Who this might be right for
Gastric CancerColon CancerRectal Cancer+4 more
Chongqing Precision Biotech Co., Ltd 60
Testing effectiveness (Phase 2)Ended earlyNCT03504774
What this trial is testing

Food Allergen OIT for Shrimp and Cashew

Who this might be right for
Allergy;FoodAllergy to ShrimpAllergy to Cashew Nut (Disorder)
Sayantani B. Sindher 58
Testing effectiveness (Phase 2)Study completedNCT02580539
What this trial is testing

The Safety and Efficacy of EBV Specific T-cell Lines

Who this might be right for
Epstein-Barr Virus InfectionsPost-Transplant Lymphoproliferative DisorderLymphoma
Dr. Jean-Sebastien Delisle, MD, PhD 12
Next Page